Two fitusiran Phase 3 studies published in The Lancet and The Lancet Haematology highlight potential to address unmet needs across all types of hemophilia
from Sanofi - Aventis Groupe https://ift.tt/4EogUx8
via IFTTT
Two fitusiran Phase 3 studies published in The Lancet and The Lancet Haematology highlight potential to address unmet needs across all types of hemophilia
0 Comments
Please ,
Do not enter any kind of span link